Orange County is the single most technology-rich epicenter for ophthalmology technology. OCTANe's annual Ophthalmology Technology Summit (OTS) will continue to build upon the rich tradition of creating a local forum where leading ophthalmology technologists, researchers, clinicians, and entrepreneurs can come together to discuss ground-breaking ophthalmic technologies, unmet clinical needs, and new business opportunities, all to fuel the ophthalmology ecosystem in Southern California. This year we are excited to announce that Brent Saunders, Allergan CEO, will begin the conference with an open discussion about technology innovation in the Ophthalmic space. OTS will feature many other luminaries in ophthalmology including: Jim Mazzo, John Hovanesian, MD, FACS, Ehsan Sadri, MD, FACS, Elizabeth Yeu-Lin, MD, Richard Lindstrom, MD, Tom Frinzi and many more. 

OTS 2O17 Agenda

See Last Year's Agenda: 

7:00 - 8:00 AM - Registration, Exhibits & Continental Breakfast

8:00 - 8:15 AM - Opening Comments

  • Bill Carpou, CEO, OCTANe        

8:15 - 9:15 AM - Interview with Johnson & Johnson CEO, Alex Gorsky, Hosted By Jim Mazzo

  • Alex Gorsky, CEO, Johnson & Johnson 

  • Jim Mazzo, Global President of Ophthalmic Devices, Carl Zeiss Meditec, Inc.

9:15 - 10:15 AM - Panel: The Customer Connection -  Industry CEO's & SVPs

  • Jim Mazzo, Global President of Ophthalmic Devices, Carl Zeiss Meditec, Inc. (MODERATOR)
  • Chris Calcattera, CCO, Glaukos

  • Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision 

  • Bill Meury, EVP & CCO, Allergan

  • Tom Mitro, President & COO, Aerie Pharmaceuticals 

  • Michael Onuscheck, Global Franchise Head, Surgical, Alcon

10:15 - 10:45 AM - Break: Exhibits & Coffee

10:45 - 11:45 AM - Panel: The Data Connection

  • John Hovanesian, MD, FACS, Harvard Eye Associates (MODERATOR)

  • Andrew Chang, Head of Global Sales - Ophthalmic Devices, Carl Zeiss Meditec, Inc.

  • Cynthia Matossian, MD, FAC Founder & Medical Director, Matossian Eye Associates - PA & NJ

  • Shankar Rao, President, Shadowbrook Systems Inc.

  • Harry Glorikian, CEO, Sr. Executive, Board Director, Author, MoneyBall Medicine & Commercializationof Novel IVD

  • Michael Onuscheck, Global Franchise Head, Surgical, Alcon

11:45 - 12:00 PM - Break: Exhibits & Coffee

12:00 - 12:45 PM - Lunch

12:45 - 1:45 PM   - Panel: Building Blocks for Practices of the Future

  • Ehsan Sadri, MD, FACS (MODERATOR)

  • Farrell "Toby" Tyson, MD, Tyson Eye CEO

  • William Wiley, MD

  • Andy Corley, Founder, Yelroc Consulting 

  • Herman Cukier, Senior Vice President, US Eye Care, Allergan 

1:45 - 2:15 PM    - Break: Exhibits and Coffee

2:15 - 2:40 PM    - Panel: Private Pay, Products, Regulation, and More

  • William J. Link, MD, Managing Director, Versant Ventures (MODERATOR)

  • Scott Whitcup, MD, CEO, Akrivista and Whitecap Biosciences

  • John W. Sheets Jr., Ph.D, Principal, ThoughStorm Innovation

  • Paul Stone, Ph.D, Associate VP - Global Regulatory Affairs, Allergan

2:40 - 3:40 PM  - The Role of Private Equity & Practice Partnership in the Future of Eye Care Delivery

  • Richard Lindstrom, MD, Founder & Attending Surgeon, Minnesota Eye Consultants, Board of                                               Directors, United Vision Partners 

  • Bruce Maller, President & CEO, BSM Consulting 

  • Brent Wilde, President, Minnesota Eye Consultants 

  • Brett Katzen, MD; President, Katzen Eye Group, CMO, Eye Services Partners

  • Sami Abbasi, CEO & President, United Vision Partners

  • Mark Rosenberg, CEO, Barnett Dulaney Perkins 

3:40 - 3:50 PM  - Closing Comments

  • Bill Carpou, CEO, OCTANe 

3:50 - 4:00 PM  - Tribute to Roger Steinert, MD

  • Jim Mazzo, Global President of Ophthalmic Devices, Carl Zeiss Meditec, Inc.

  • Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision

4:15 - 6:00 PM  - General Reception


Contact: Cameron Cline

(949) 330 - 6567